The management of succinylcholine apnoea.
Barker
I
I
D001049:Apnea / Q000139:chemically induced* / Q000628:therapy; D017848:Blood-Borne Pathogens; D006801:Humans; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects*; D013390:Succinylcholine / Q000009:adverse effects*
D009467:Neuromuscular Depolarizing Agents; D013390:Succinylcholine